Protelight Pharmaceuticals

Jiangyin, China · Founded 2009 · In IPO Registration

Developer and manufacturer of novel antimicrobial peptide drugs and therapeutic candidates designed for drug-resistant infections, metabolic disorders, and autoimmune diseases. Protelight Pharmaceuticals is based in Jiangyin, China and was founded in 2009. Its last reported valuation was $352 million in Nov 2025. It has raised $115 million.

Last reported valuation
$351.9M
Oct 2026
Priced at
—
Total raised
$115.0M
Last round
—

Who backs Protelight Pharmaceuticals?

12 investors
InvestorType
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Infinity GroupPE / buyout
Wuxi Guolian Development (Group)Other
Cherami Investment GroupAsset manager
Qingdao Conson Financial HoldingsOther
PICC Capital Equity Investment CompanyOther
Jiangsu Jincai InvestmentOther
Hangzhou Tigermed Consulting Company—
Huajin Venture Capital—
Jiangyin New Guolian Venture Capital—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Protelight Pharmaceuticals investors

12 investors are on record for Protelight Pharmaceuticals, including Shenzhen Yifeng Investment Management Enterprise, Infinity Group, Wuxi Guolian Development (Group) and Cherami Investment Group.

Free account
More of Protelight Pharmaceuticals with a free account
  • ·The complete investor list: 12 names
  • ·Watch Protelight Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Protelight Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View